October 30, 2013

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

A therapeutic hypothesis for glucose intolerance after cerebral ischemia

Interestingly, a recent study found that ischemic stress causes hyperglycemia and may worsen ischemic neuronal damage. In addition, decreased insulin sensitivity after ischemic stress seems to be involved in the development of post-ischemic glucose intolerance. However, the involvement of brain-derived neurotrophic factor in the development of glucose intolerance following ischemic stress still remains unclear.

Xiaoliang Shu and colleagues from the Affiliated Dongfang Hospital of Tongji University, China found that after cerebral ischemia, the expression levels of brain-derived neurotrophic factor and tyrosine kinase B receptor were significantly decreased in the hypothalamus. However, intrahypothalamic administration of brain-derived neurotrophic factor suppressed the decrease in insulin receptor and tyrosine-phosphorylated expression in the liver and skeletal muscle, and inhibited the overexpression of gluconeogenesis-associated phosphoenolpyruvate carboxykinase and glucose-6-phosphatase in the liver of cerebral ischemic mice. In addition, serum insulin levels remained unchanged. The researchers believed that after cerebral ischemia can be improved by suppressing the loss of brain-derived neurotrophic factor in the hypothalamus.

These findings were published in the Neural Regeneration Research (Vol. 8, No. 25, 2013).

More information: Shu XL, Zhang YS, Xu H, Kang K, Cai DL. Brain-derived neurotrophic factor inhibits glucose intolerance after cerebral ischemia. Neural Regen Res. 2013;8(25):2370-2378.

Provided by Neural Regeneration Research

Load comments (0)